Acetylcholinesterase Inhibition Assays for High-Throughput Screening.

AChE inhibitors Acetylcholinesterase (AChE) Cell-based AChE inhibition assay Enzyme-based AChE inhibition assay High-throughput screening Liver microsomes Pesticides

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
entrez: 16 3 2022
pubmed: 17 3 2022
medline: 19 3 2022
Statut: ppublish

Résumé

Acetylcholinesterase (AChE) hydrolyzes acetylcholine (ACh), a vital neurotransmitter that regulates muscle movement and brain function, including memory, attention, and learning. Inhibition of AChE activity can cause a variety of adverse health effects and toxicity. Identifying AChE inhibitors quickly and efficiently warrants developing AChE inhibition assays in a quantitative, high-throughput screening (qHTS) platform. In this chapter, protocols for multiple homogenous AChE inhibition assays used in a qHTS system are provided. These AChE inhibition assays include a (1) human neuroblastoma (SH-SY5Y) cell-based assay with fluorescence or colorimetric detection; (2) human recombinant AChE with fluorescence or colorimetric detection; and (3) combination of human recombinant AChE and liver microsomes with colorimetric detection, which enables detection of test compounds requiring metabolic activation to become AChE inhibitors. Together, these AChE assays can help identify, prioritize, and predict chemical hazards in large compound libraries using qHTS systems.

Identifiants

pubmed: 35294755
doi: 10.1007/978-1-0716-2213-1_6
pmc: PMC9440486
mid: NIHMS1831756
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-58

Subventions

Organisme : Intramural NIH HHS
ID : ZIA TR000038
Pays : United States

Informations de copyright

© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Références

Biotechnol J. 2017 May;12(5):
pubmed: 28294544
ALTEX. 2018 Mar 8;35(2):163-168
pubmed: 29529324
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11473-8
pubmed: 16864780
Curr Neuropharmacol. 2013 May;11(3):315-35
pubmed: 24179466
Br J Pharmacol. 2007 Sep;152(1):53-61
pubmed: 17603542
Nat Rev Neurosci. 2001 Apr;2(4):294-302
pubmed: 11283752
Drug Discov Today. 2013 Aug;18(15-16):716-23
pubmed: 23732176
Chem Res Toxicol. 2013 Jun 17;26(6):878-95
pubmed: 23611293
J Pharmacol Toxicol Methods. 2015 Nov-Dec;76:15-22
pubmed: 26165232
Environ Health Perspect. 2021 Apr;129(4):47008
pubmed: 33844597
CNS Drugs. 2001;15(5):375-90
pubmed: 11475943
Toxicol In Vitro. 2019 Apr;56:93-100
pubmed: 30625376
Nat Chem Biol. 2007 Aug;3(8):466-79
pubmed: 17637779
PLoS One. 2015 Dec 07;10(12):e0144337
pubmed: 26642212

Auteurs

Shuaizhang Li (S)

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Andrew J Li (AJ)

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Jinghua Zhao (J)

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Michael F Santillo (MF)

Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD, USA.

Menghang Xia (M)

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA. mxia@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH